Stocks and InvestingStocks and Investing
Fri, January 21, 2022
Thu, January 20, 2022
Wed, January 19, 2022
Tue, January 18, 2022

Andrew Fein Maintained (BIIB) at Strong Buy with Decreased Target to $270 on, Jan 18th, 2022


Published on 2024-10-27 19:18:20 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $452 to $270 on, Jan 18th, 2022.

Andrew has made no other calls on BIIB in the last 4 months.



There are 19 other peers that have a rating on BIIB. Out of the 19 peers that are also analyzing BIIB, 12 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $202 on, Thursday, January 13th, 2022
  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $216 on, Wednesday, January 12th, 2022
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $195 on, Wednesday, January 12th, 2022
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $207 on, Wednesday, January 12th, 2022
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $275 on, Thursday, December 23rd, 2021
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Decreased Target to $276 on, Tuesday, December 21st, 2021
  • Brian Skorney of "Baird" Maintained at Hold with Decreased Target to $258 on, Tuesday, December 21st, 2021
  • Mohit Bansal of "Wells Fargo" Initiated at Hold and Held Target at $250 on, Thursday, December 9th, 2021
  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $271 on, Monday, December 6th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021


These are the ratings of the 7 analyists that currently disagree with Andrew


  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $292 on, Wednesday, January 12th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $350 on, Wednesday, December 22nd, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $325 on, Monday, December 20th, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021